1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
653E18970742E4672852571AE0053AC09
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/sales-force-effectiveness-sales-force-structure-alignment-and-resources-required-to-service-the-us-hospital-marketplace?opendocument
18
19opendocument
2034.228.38.35
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales Leadership Sales Force Effectiveness

Pharmaceutical Sales Force Effectiveness: Alignment, Structure and Support to Serve the U.S. Hospital Marketplace

ID: 4909


Features:

9 Info Graphics

33 Data Graphics

282 Metrics


Pages/Slides: 53


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

Non-members: Click here to see a complimentary overview of "Pharmaceutical Sales Force Effectiveness: Alignment, Structure and Support to Serve the U.S. Hospital Marketplace"

Study Overview
What is the optimal approach to structure, align and support a hospital sales force to ensure that your products are effectively represented on formularies?

One of the primary challenges pharmaceutical companies face is how to organize and align sales groups to effectively penetrate the hospital marketplace. This benchmark study was designed to assist pharmaceutical and biotech organizations gain insights into hospital sales force structure, alignment and support - by hospital market segment - to better meet the needs of the hospital marketplace customer.

This study examines how biopharma companies align, structure and support sales to serve these market segments: Community hospitals, regional hospital networks, multi-state networks, academic medical centers and VA hospitals. Pharmaceutical sales executives can use this study to compare their hospital sales group's alignment, structure and support for serving the U.S. hospital marketplace.

The study contains data from 2011 and presents longitudinal data from 2008 that allows hospital sales leaders to see emerging trends in the hospital marketplace.

Key Topics

  • Hospital Sales Force Structure, Alignment And Support
  • Sales Force Structure, Alignment And Support for Community Hospitals
  • Sales Force Structure, Alignment And Support for Regional IDN/IDS
  • Sales Force Structure, Alignment And Support for Multi-state IDN/IDS
  • Sales Force Structure, Alignment And Support for Academic Medical Centers
  • Sales Force Structure, Alignment And Support for VA Hospitals

Sample Key Metrics
  • Who has oversight for the sales force that serves the hospital marketplace
  • Hospital market segments served by hospital sales group
  • Number of hospitals or networks in each of the market segment targeted
  • Total FTEs that make up U.S. hospital sales force
  • Hospital Sales Force Alignment - Percent of hospital sales force aligned by brand, disease state or portfolio.
  • Hospital Sales Force Structure - Percent of hospital sales force structured by the traditional representative model, the account executive model or the hybrid model.
  • Hospital Sales Force Support - Percent of hospital sales force receiving sales support from a defined hospital sales support group, by brand or by therapeutic area

Methodology
This research originated from a Best Practices, LLC research and consulting project. It was conducted for a pharmaceutical client and was based on surveys with executives and senior managers from 12 pharmaceutical and biotech organizations.

Industries Profiled:
Pharmaceutical; Health Care; Medical Device; Biotech; Diagnostic


Companies Profiled:
Lundbeck; Fresenius Medical Services; North America; Boehringer Ingelheim; Covidien; Pfizer; Johnson & Johnson Healthcare Systems; Medtronic; Abbott Laboratories; LabCorp; GlaxoSmithKline; Eisai; Roche


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.